Covered recipient · General Payments record
JOHN T CHON
Allopathic & Osteopathic Physicians Emergency Medicine
General Payments · PY2020–2024
$1,559.69
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $684.37 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $370.70 | 3 |
| ABBVIE INC. | $194.22 | 12 |
| Gilead Sciences, Inc. | $102.52 | 4 |
| BOSTON SCIENTIFIC CORPORATION | $16.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.07 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465754 | CMS |
| ABBVIE INC. | $15.33 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465756 | CMS |
| ABBVIE INC. | $26.38 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465758 | CMS |
| ABBVIE INC. | $13.73 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465760 | CMS |
| ABBVIE INC. | $27.08 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465762 | CMS |
| ABBVIE INC. | $14.99 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465764 | CMS |
| ABBVIE INC. | $16.10 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465766 | CMS |
| ABBVIE INC. | $10.01 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465768 | CMS |
| ABBVIE INC. | $30.21 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465770 | CMS |
| ABBVIE INC. | $3.13 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465772 | CMS |
| ABBVIE INC. | $11.52 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465774 | CMS |
| ABBVIE INC. | $4.67 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103465776 | CMS |
| AstraZeneca Pharmaceuticals LP | $117.24 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105871903 | CMS |
| AstraZeneca Pharmaceuticals LP | $132.31 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104455660 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.15 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105691677 | CMS |
| Boston Scientific Corporation | $16.93 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092706826 | CMS |
| Gilead Sciences, Inc. | $26.82 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133632864 | CMS |
| Gilead Sciences, Inc. | $32.11 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133632866 | CMS |
| Gilead Sciences, Inc. | $19.00 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133632868 | CMS |
| Gilead Sciences, Inc. | $24.59 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133632870 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.